Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Clemastine fumarate |
Is a |
False |
Clemastine (substance) |
Inferred relationship |
Some |
|
Clemastine adverse reaction |
Causative agent (attribute) |
True |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Allergy to clemastine (finding) |
Causative agent (attribute) |
False |
Clemastine (substance) |
Inferred relationship |
Some |
|
Clemastine+phenylpropanolamine 0.5/25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clemastine (substance) |
Inferred relationship |
Some |
|
Product containing precisely clemastine 1 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clemastine (substance) |
Inferred relationship |
Some |
|
Clemastine 500micrograms/5mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clemastine (substance) |
Inferred relationship |
Some |
|
Product containing clemastine and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Clemastine 1.34mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clemastine (substance) |
Inferred relationship |
Some |
|
Product containing precisely clemastine 1.34 milligram and phenylpropanolamine 75 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clemastine (substance) |
Inferred relationship |
Some |
|
Product containing clemastine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely clemastine 1.34 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clemastine (substance) |
Inferred relationship |
Some |
|
Allergy to clemastine (finding) |
Causative agent (attribute) |
True |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely clemastine 1 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely clemastine 1 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely clemastine 1.34 milligram and phenylpropanolamine 75 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely clemastine 1.34 milligram and phenylpropanolamine 75 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely clemastine 1.34 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely clemastine 1.34 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Clemastine fumarate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Clemastine (substance) |
Inferred relationship |
Some |
|
Product containing precisely clemastine 1 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely clemastine 1.34 milligram and phenylpropanolamine 75 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely clemastine 1.34 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Product containing clemastine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Clemastine- and phenylpropanolamine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Product containing clemastine and paracetamol and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Product containing clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Clemastine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Clemastine and paracetamol and phenylpropanolamine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Product containing only clemastine and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Clemastine and phenylpropanolamine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Product containing only clemastine and paracetamol and phenylpropanolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Product containing only clemastine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clemastine (substance) |
Inferred relationship |
Some |
1 |
Clemastine (as clemastine fumarate hydrochloride) 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clemastine (substance) |
Inferred relationship |
Some |
1 |